<b>Bone - Anatomia ossis</b> | Interpretable prognosis for susceptibility to active anti-cancer molecular forms, based on amides/carboxylic acids - hydrolysis derivatives of natural nitrile glycosides, of transcriptome cell lines inherent in tumors

<p dir="ltr">excerpt from an edition:</p><p dir="ltr"><b>A T L A S</b> - Interpretable prognosis for susceptibility to active anti-cancer molecular forms, based on amides/carboxylic acids - hydrolysis derivatives of natural nitrile glycosides, of transcriptome cell lines inherent in tumors /Second supplemented edition/ - DOI: <a href="http://doi.org/10.5281/zenodo.13777292" rel="noreferrer" target="_blank">10.5281/zenodo.13777292</a> | ISBN: 978-619-91534-6-8</p><p>--------------</p><p dir="ltr">From the data on the interpretable prognosis of sensitivity to active anti-cancer molecular forms (p.10 form the ATLAS) of transcriptome cell lines inherent in tumors in the <b><i>Bone</i></b> (<b><i>a.</i></b> & <b><i>b.</i></b>), it is concluded that:</p><p dir="ltr"><b>- some of the main potential medicines: </b></p><p dir="ltr"><i>2-methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)propanamide</i> and <i>.../propanoic acid</i> in stoichiometric ratio by mass 4.87:1 is released inside the cancer cell<i> 2-hydroxy-2-methylpropanamide</i> and <i>.../propanoic acid </i>,</p><p dir="ltr"><i>(R)-2-(((2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)methyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-2-methylbutanamide</i> and <i>.../butanoic acid </i>in stoichiometric ratio by mass 4.87:1 is released inside the cancer cell <i>(R)-2-hydroxy-2-methylbutanamide</i> and <i>.../butanoic acid</i> ,</p><p dir="ltr"><i>(2S,3S)-2-hydroxy-4-methoxy-1-methyl-6-oxo-3-(((2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,2,3,6-tetrahydropyridine-3-carboxamide</i> and <i>.../carboxylic acid</i> in stoichiometric ratio by mass 4.87:1 is released inside the cancer cell <i>(2S,3S)-2,3-dihydroxy-4-methoxy-1-methyl-6-oxo-1,2,3,6-tetrahydropyridine-3-carboxamide</i> and <i>.../carboxylic acid</i> ,</p><p dir="ltr"><i>(2S,3R)-2-hydroxy-4-methoxy-1-methyl-6-oxo-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,2,3,6-tetrahydropyridine-3-carboxamide</i> and<i> .../carboxylic acid</i> in stoichiometric ratio by mass 4.87:1 is released inside the cancer cell <i>(2S,3R)-2,3-dihydroxy-4-methoxy-1-methyl-6-oxo-1,2,3,6-tetrahydropyridine-3-carboxamide</i> and <i>.../carboxylic acid</i> ,</p><p dir="ltr"><i>(Z)-2-((2S,3R,4S,6R)-2,3-dihydroxy-4-methoxy-6-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)cyclohexylidene)acetamide</i> and <i>.../acetic acid</i> in stoichiometric ratio by mass 4.87:1 is released inside the cancer cell<i> (E)-2-((2S,3R,4S,6R)-2,3,6-trihydroxy-4-methoxycyclohexylidene)acetamide</i> and <i>.../acetic acid</i> ,</p><p dir="ltr">the rest ACCF can be found in the file and the ATLAS ;</p><p dir="ltr"><b>- certain medicines for duplication of treatment and/or replacement for medical reasons: </b></p><p dir="ltr"><i>2-(3-hydroxy-4-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)phenyl)acetamide</i> and <i>.../acetic acid</i> in stoichiometric ratio by mass 4.87:1 is released inside the cancer cell <i>2-(3,4-dihydroxyphenyl)acetamide</i> and <i>.../acetic acid</i> ,</p><p dir="ltr"><i>(R)-2-(3-hydroxy-4-methoxyphenyl)-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)acetamide</i> and <i>.../acetic acid</i> in stoichiometric ratio by mass 4.87:1 is released inside the cancer cell <i>(R)-2-hydroxy-2-(3-hydroxy-4-methoxyphenyl)acetamide</i> and <i>.../acetic acid</i> ,</p><p dir="ltr"><i>((2R,3S,4S,5R,6R)-6-(((2R,3S)-4-amino-3-methyl-4-oxobutan-2-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methyl (2S,3R)-2-ethyl-2,3-dihydroxybutanoate</i> and <i>(2S,3R)-3-(((2R,3R,4S,5S,6R)-6-((((2S,3R)-2-ethyl-2,3-dihydroxybutanoyl)oxy)methyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-2-methylbutanoic acid </i>in stoichiometric ratio by mass 4.87:1 is released inside the cancer cell <i>(2S,3R)-3-hydroxy-2-methylbutanamide</i> and <i>.../butanoic acid</i> ,</p><p dir="ltr">the rest ACCF can be found in the file and the ATLAS.</p><p>-------</p><p dir="ltr"><b><u>Important! Do not forget to comply with the current clinical control. </u></b></p>